BSEAstal Laboratories LtdMediumNeutral
Announced Thu, 14 May · 12:16 IST

Submission of intimation of resignation of statutory auditors of Sriven Pharmachem India Private limited a material subsidiary of the Company.

Auditor Resigned MidtermManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹81.49
prior close
₹80.01
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+1.4+1.4+1.4+0.0-3.1-4.3-3.5-5.6-11.6-10.7-0.7+2.0
Up moveDown movePending
AI summary

Astal Laboratories Ltd has disclosed the resignation of M/s. Balaji V & Co. as Statutory Auditors of its wholly owned material subsidiary, Sriven Pharmachem India Private Limited, effective May 13, 2026. The auditors were appointed on August 6, 2025, for a term scheduled to expire on March 31, 2030, making this a mid-term resignation. The reason stated is that SEBI now mandates a Peer Review Certificate for auditors of material subsidiaries of listed companies, and Balaji V & Co. had not yet received this certificate despite having applied for it. The auditors confirmed they had not commenced or completed the audit for the quarter and financial year ended March 31, 2026. The matter was communicated to the company's Audit Committee prior to resignation.

Likely market impact

This mid-term resignation of auditors from a material subsidiary raises concerns about potential delays in financial reporting for that subsidiary. Shareholders should monitor for appointment of replacement auditors and any impact on the timeline for releasing subsidiary financials.